Emcrown Clinical Research

EmcrownOngoing Studies

Click here to participate in any ongoing study.

We are currently enrolling participants for studies in the following areas:

1. Uninary Tract Infection (NCT05488340)

Are you a female with recurring UTI’s?
We have an ongoing study to determine the safety and efficacy of a medication to treat drug-resistant UTI’s

2. Chronic Kidney Disease (NCT06087835)

Do you have Chronic Kidney Disease (CKD) with high levels of protein in your urine? Emcrown is conducting a phase-3 research to find out whether combining zibotentan with dapagliflozin may help in people with CKD, especially those with high proteinuria.

3. Tourette’s Disorder (NCT06021522)

Tourette’s affects millions of children, adults and adolescents globally. This study seeks to test the efficacy of Ecopipam that can potentially help.

4. Hypertension. (NCT06272487)

Many people struggle to keep their blood pressure under control, even with prescription medications. This study aims to evaluate if zilebesiran can safely lower blood pressure in people with high blood pressure who are taking 2 to 4 hypertension medications and have an increased risk of experiencing a cardiovascular event.

Why Participate in a Study? Click Here to Learn More on Clinical Research

Get in touch with Our Team to know the recruiting studies and how you can participate.